38 results
DEFM14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Proxy related to merger
7:44am
.
AbbVie is a global, research-based biopharmaceutical company. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop … to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie’s principal executive
PRER14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Preliminary revised proxy
7:19am
and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie’s … biopharmaceutical company. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies
PREM14A
CERE
Cerevel Therapeutics Holdings Inc
5 Jan 24
Preliminary proxy related to merger
5:13pm
, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious … , research-based biopharmaceutical company. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced
DEFA14A
6s6xgh 0f7
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-99.1
tj9u9cpdqrcdfx8al92z
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-99.1
np22128igxka73
2 Aug 23
Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
6:43am
8-K
EX-99.1
lzs38w2xpripp
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am
424B4
0uwu91qm p2lxl
2 Jul 21
Prospectus supplement with pricing info
5:22pm
424B3
g3yz 268xk36mvl
29 Jun 21
Prospectus supplement
6:57am
8-K
EX-99.2
b7t4j49n fw
29 Jun 21
Cerevel Therapeutics Announces Positive Topline Results for CVL-231 in Phase 1b
6:52am
DRS
vfartxex
27 May 21
Draft registration statement
12:00am